News room

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Media contact


Nicklas Westerholm, CEO

Yilmaz Mahshid, CFO


Calendar and upcoming reports

February 22, 2024
Year-end Report Q4 2023

March 5-6, 2024
Carnegie Nordic Healthcare Seminar

Show more events



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10